Status: Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
The purpose of this study is to evaluate the safety and efficacy of pumitamig in combination with chemotherapy versus bevacizumab in combination with chemotherapy in participants with previously untreated, unresectable, or metastatic colorectal cancer
Participants needed: 990
Trial details
Phase: Phase 2, Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Bristol-Myers SquibbUpdated: Aug 17, 2026Locations: 283
Eligibility criteria
Participant must previously untreated, histologically confirmed recurrent or met... [+3]
Participant must not have any untreated known central nervous system (CNS) metas... [+4]